ArticleScience advances2026

A noncanonical function of the tyrosine degradation enzyme FAH drives CDK4/6 inhibitor resistance in breast cancer.

Jenny Högström et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.